2021年我国脑卒中防治主要工作进展回顾及2022年工作规划

doi:10.11817/j.issn.1673-9248.2022.02.001

中华脑血管病杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 71 -75. doi: 10.11817/j.issn.1673-9248.2022.02.001

专家论坛

2021年我国脑卒中防治主要工作进展回顾及2022年工作规划

巢宝华¹, 王凌霄¹, 樊帅¹, 涂文军¹, 曹雷¹, 王陇德¹^,^†(

)

^1. 100053　北京，国家卫生健康委员会脑卒中防治工程委员会办公室

收稿日期:2022-03-16 出版日期:2022-04-01
通信作者: 王陇德

Stroke prevention and control in China: round-up 2021 and prospects 2022

Baohua Chao¹, Lingxiao Wang¹, Shuai Fan¹, Wenjun Tu¹, Lei Cao¹, Longde Wang¹^,^†()

^1. The General Office of Stroke Prevention Project Committee, National Health Commission of the People's Republic of China, Beijing 100053, China

Received:2022-03-16 Published:2022-04-01
Corresponding author: Longde Wang

全文 ( ) 下载PDF ( ) 导出引用

脑卒中是我国居民致死致残的主要原因。为了应对卒中挑战，2011 年 4 月，原卫生部中国脑卒中防治工程委员会（CSPPC）成立，该委员会积极推动中国脑卒中预防和控制工作。2021年CSPPC有序推进脑卒中高危人群筛查和干预、卒中中心建设、适宜技术推广、专病分级诊疗、健康宣教等工作，取得了优异成绩。在2022年，CSPPC将主要开展以下工作：加强卒中中心建设，推进区域协作工作；加强适宜技术培训，提升卒中救治成效；高质量开展脑卒中高危人群筛查工作；持续普及健康知识；深入开展患者随访管理，提升全民健康素养。

关键词: 脑卒中, 防控, 目标

Stroke is one of the leading causes of mortality and disability in China. Facing the challenge of stroke, China Stroke Prevention Project Committee (CSPPC) was established in April 2011 under the leading of the Ministry of Health. The CSPPC actively promotes and stroke prevention and control in China. In 2021, CSPPC has obtained remarkable achievements as following: high-risk stroke population screening and the relevant intervention, construction of stroke centers, promotion of appropriate stroke treatment technologies, tiered diagnosis and treatment of stroke, and health education. In 2022, CSPPC will mainly carry out the following tasks: strengthening the construction of stroke centers and promote regional collaboration; strengthening appropriate technical training to improve the effectiveness of stroke treatment; carrying out high-quality screening of high-risk stroke populations; continuing to popularize health knowledge; perfroming follow up of patients with stroke and improving the health education in general population.

Key words: Stroke, Prevention and control, Target

1	Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study [J]. BMJ, 2020, 369: m997.
2	Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project) [J]. Lancet, 2017, 390(10112): 2549-2558.
3	Tu WJ, Zeng X, Liu Q. Aging tsunami coming: the main finding from China’s seventh national population census [J]. Aging Clin Exp Res, 2021. Online ahead of print.
4	Chao BH, Yan F, Hua Y, et al. Stroke prevention and control system in China: CSPPC-stroke program [J]. Int J Stroke, 2021, 16(3): 265-272.
5	Tu WJ, Yan F, Chao BH, et al. Stroke-unit care for stroke patients in China: the results from bigdata observatory platform for stroke of China [J]. J Neurol, 2021, 268(11): 4213-4220.
6	Geng C, Li SD, Zhang DD, et al. Endovascular thrombectomy versus bridging thrombolysis: real‐world efficacy and safety analysis based on a nationwide registry study [J]. J Am Heart Assoc, 2021, 10(3): e018003.
7	Tu WJ, Chao BH, Ma L, et al. Case-fatality, disability and recurrence rates after first-ever stroke: a study from bigdata observatory platform for stroke of China [J]. Brain Res Bull, 2021, 175: 130-135.
8	Tu W, Yan F, Chao B, et al. Status of hyperhomocysteinemia in China: results from the China Stroke High-risk Population Screening Program, 2018 [J]. Front Med, 2021, 15(6): 903-912.
9	Zi W, Qiu Z, Li F, et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke: the DEVT randomized clinical trial [J]. JAMA, 2021, 325(3): 234-243.
10	Wang Y, Meng X, Wang A, et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA [J]. N Engl J Med, 2021, 385(27): 2520-2530.
11	Neal B, Wu Y, Feng X, et al. Effect of salt substitution on cardiovascular events and death [J]. N Engl J Med, 2021, 385(12): 1067-1077.
12	Lu X, Niu X, Shen C, et al. Development and validation of a polygenic risk score for stroke in the Chinese population [J]. Neurology, 2021, 97(6): e619-e628.

[1]	张怡, 王宇洋, 司梦娇, 曹燕, 李欢欢. 脑卒中前白蛋白与肺炎发生风险相关性分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 648-651.
[2]	杨金朔, 吴桥伟, 王春雷, 史怀璋. 脑血管内支架成形术后再狭窄的研究进展[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(03): 174-179.
[3]	江西省神经外科质量控制中心. 江西省心源性脑卒中多学科协作防治专家共识[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 264-277.
[4]	张洪, 杨琪, 罗静, 唐茜, 邓鸿, 巩文艳, 王丽坤, 刘静, 艾双春. 多靶点神经调控技术对卒中后上肢运动功能障碍患者的脑网络功能连接研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 278-284.
[5]	许方军, 曹晓光, 王修敏, 王婷, 陈冬冬, 余程冬, 张鹤言. 基于闭环理论的动作观察疗法联合躯干控制训练对脑卒中后下肢运动的影响[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 292-299.
[6]	张雅文, 尹昱, 陈江龙, 杨玉慧, 吕红香, 张琦, 吕佩源. Theta爆发式经颅磁刺激治疗失语症的研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 306-311.
[7]	陈冬冬, 余程冬, 曹晓光. 上肢外骨骼机器人在脑卒中康复中的应用与研究进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 312-317.
[8]	吉莉, 苏云楠, 王斌, 沈滔, 刘团结, 毛蕾, 徐玉萍, 张婷, 王博. 急性缺血性脑卒中患者脑白质微结构改变对长期认知功能损伤的预测价值研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 193-200.
[9]	杨钲, 彭鑫鑫, 王响, 李俊杰, 巩承舜, 宋光彩. 健康中国战略背景下四川省西昌市居民日本血吸虫病防治知识及态度行为研究[J/OL]. 中华临床实验室管理电子杂志, 2024, 12(04): 221-228.
[10]	李璇, 邓岚, 郭微, 邓永梅, 刘杰昕. 标准化皮肤管理流程在防治脑卒中患者失禁相关性皮炎中的应用[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 479-482.
[11]	刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[12]	王丽娜, 吕书霞, 李亚男. 脑卒中偏瘫患者健康焦虑元认知与疾病接受度、恐惧疾病进展的相关性[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 434-440.
[13]	周洪千, 张煜坤, 顾天舒, 胡苏涛, 姜超, 张雪, 张昊, 陶华岳, 刘行, 刘彤, 陈康寅. 既往出血性脑卒中患者行经皮冠脉介入治疗后不良事件的危险因素分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 323-329.
[14]	邓越, 白鹏, 洪秋阳, 王桂玲. 颈部七线调衡疗法探析并病例汇报一例[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 345-349.
[15]	李芳, 戴西望, 王凯, 郭廷昊, 涂江龙. 非瓣膜性心房颤动相关性卒中的治疗研究进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(04): 393-397.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Stroke prevention and control in China: round-up 2021 and prospects 2022

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Stroke prevention and control in China: round-up 2021 and prospects 2022